CellaVision AB Statistics

Total Valuation

CellaVision AB has a market cap or net worth of GBP 329.73 million. The enterprise value is 320.62 million.

Market Cap	329.73M
Enterprise Value	320.62M

Important Dates

The last earnings date was Thursday, February 6, 2025.

Earnings Date	Feb 6, 2025
Ex-Dividend Date	May 7, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.00%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	19.81M

Valuation Ratios

The trailing PE ratio is 32.47.

PE Ratio	32.47
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	7.66
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 19.73, with an EV/FCF ratio of 23.83.

EV / Earnings	31.57
EV / Sales	5.96
EV / EBITDA	19.73
EV / EBIT	24.28
EV / FCF	23.83

Financial Position

The company has a current ratio of 3.72, with a Debt / Equity ratio of 0.03.

Current Ratio	3.72
Quick Ratio	2.56
Debt / Equity	0.03
Debt / EBITDA	0.12
Debt / FCF	0.14
Interest Coverage	21.78

Financial Efficiency

Return on equity (ROE) is 18.37% and return on invested capital (ROIC) is 13.68%.

Return on Equity (ROE)	18.37%
Return on Assets (ROA)	11.44%
Return on Invested Capital (ROIC)	13.68%
Return on Capital Employed (ROCE)	19.66%
Revenue Per Employee	228,935
Profits Per Employee	44,546
Employee Count	228
Asset Turnover	0.75
Inventory Turnover	1.88

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -24.77% in the last 52 weeks. The beta is 1.23, so CellaVision AB's price volatility has been higher than the market average.

Beta (5Y)	1.23
52-Week Price Change	-24.77%
50-Day Moving Average	211.96
200-Day Moving Average	245.76
Relative Strength Index (RSI)	32.60
Average Volume (20 Days)	169

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, CellaVision AB had revenue of GBP 52.20 million and earned 10.16 million in profits. Earnings per share was 0.43.

Revenue	52.20M
Gross Profit	35.15M
Operating Income	12.82M
Pretax Income	12.76M
Net Income	10.16M
EBITDA	15.78M
EBIT	12.82M
Earnings Per Share (EPS)	0.43

Full Income Statement

Balance Sheet

The company has 10.78 million in cash and 1.94 million in debt, giving a net cash position of 8.85 million.

Cash & Cash Equivalents	10.78M
Total Debt	1.94M
Net Cash	8.85M
Net Cash Per Share	n/a
Equity (Book Value)	58.87M
Book Value Per Share	2.47
Working Capital	21.20M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 14.32 million and capital expenditures -865,651, giving a free cash flow of 13.46 million.

Operating Cash Flow	14.32M
Capital Expenditures	-865,651
Free Cash Flow	13.46M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 67.35%, with operating and profit margins of 24.57% and 19.46%.

Gross Margin	67.35%
Operating Margin	24.57%
Pretax Margin	24.45%
Profit Margin	19.46%
EBITDA Margin	30.24%
EBIT Margin	24.57%
FCF Margin	25.78%

Dividends & Yields

This stock pays an annual dividend of 0.17, which amounts to a dividend yield of 0.09%.

Dividend Per Share	0.17
Dividend Yield	0.09%
Dividend Growth (YoY)	-5.62%
Years of Dividend Growth	n/a
Payout Ratio	38.14%
Buyback Yield	0.00%
Shareholder Yield	0.09%
Earnings Yield	3.08%
FCF Yield	4.08%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a